Quercetin has been studied extensively with drug delivery systems due to the drug's needs to improve in solubility, but usually the systems are complicated, evading the practical aspects and potential applications. This problem is expected to be solved using the simplistic micelles, in combination with the materials mPEG and cholesterol to gain advantages from the nano‐size, while increasing its overall stability and drug releasing. In this study PEGylated‐cholesterol micelles were prepared by co‐solvent method in 4 different drug‐polymer ratios, which were then characterized by physical–chemical, in vitro analyses and emphasized on the in vivo cytotoxicity test by H&E staining histological assay on Danio rerio model. The results show promising features of nano‐micelles as a passive drug delivery system in size, CMC value, and prolonged drug releasing profile. Compared to free QCT, the micelles‐loaded system exhibited significantly higher toxicity in vitro, which were also demonstrated in in vivo models, where the drug‐loaded micellar systems posed mild tissue changes, while blank micelles and free quercetin were almost harmless to the animals. The results had concluded that effective delivering of micellar system does not require advanced material‐composition, rather a throughout understanding of the interactions of nano‐properties and the materials with bio‐systems.
Tissue regeneration-promoting and drug-eluting biomaterials are commonly implanted into animals as a part of late-stage testing before committing to human trials required by the government. Because the trials are very expensive (e.g., they can cost over a billion U.S. dollars), it is critical for companies to have the best possible characterization of the materials' safety and efficacy before it goes into a human. However, the conventional approaches to biomaterial evaluation necessitate sacrificial analysis (i.e., euthanizing a different animal for measuring each time point and retrieving the implant for histological analysis), due to the inability to monitor how the host tissues respond to the presence of the material in situ. This is expensive, inaccurate, discontinuous, and unethical. In contrast, our manuscript presents a novel microfluidic platform potentially capable of performing non-disruptive fluid manipulations within the spatial constraints of an 8 mm diameter critical calvarial defect—a “gold standard” model for testing engineered bone tissue scaffolds in living animals. In particular, here, addressable microfluidic plumbing is specifically adapted for the in vivo implantation into a simulated rat's skull, and is integrated with a combinatorial multiplexer for a better scaling of many time points and/or biological signal measurements. The collected samples (modeled as food dyes for proof of concept) are then transported, stored, and analyzed ex vivo, which adds previously-unavailable ease and flexibility. Furthermore, care is taken to maintain a fluid equilibrium in the simulated animal's head during the sampling to avoid damage to the host and to the implant. Ultimately, future implantation protocols and technology improvements are envisioned toward the end of the manuscript. Although the bone tissue engineering application was chosen as a proof of concept, with further work, the technology is potentially versatile enough for other in vivo sampling applications. Hence, the successful outcomes of its advancement should benefit companies developing, testing, and producing vaccines and drugs by accelerating the translation of advanced cell culturing tech to the clinical market. Moreover, the nondestructive monitoring of the in vivo environment can lower animal experiment costs and provide data-gathering continuity superior to the conventional destructive analysis. Lastly, the reduction of sacrifices stemming from the use of this technology would make future animal experiments more ethical.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.